Unfabled secures $1.7 million in funding and expands distribution to 737 Boots UK stores, enhancing its presence in the women's health sector while attracting significant investment from Arāya Ventures and female investors.

Information on the Target

Unfabled, founded in 2021 by ex-Unilever executive Hannah Samano, specializes in women's health and has successfully raised $1.7 million in its latest funding round. This brings the total seed funding to $3.9 million. The company has also expanded its presence to 737 Boots UK stores, significantly increasing its market reach.

The recent funding round attracted new investors, including Arāya Ventures, which was established by Managing Partner Rupa Popat and supported by British Business Investments (BBI). This deal marks BBI's inaugural commitment to a solo general partner. Other notable investors from previous funding rounds include Morgan Stanley, Exceptional Ventures, Atomico Angels, and various angel groups from Google and MIT.

Industry Overview in the Target's Country

The UK wellness and health industry is experiencing substantial growth, driven by increasing consumer awareness around health and wellness. Trends show that wellness products, particu

View Source

Similar Deals

Cardumen Capital Biographica

2026

Seed Stage Biotechnology & Medical Research (NEC) United Kingdom
Cornerstone Gladys

2025

Seed Stage Home Healthcare Services United Kingdom
The Yield Lab NoBACZ Healthcare

2025

Seed Stage Bio Medical Devices United Kingdom
Sofinnova Partners Forth Therapeutics

2025

Seed Stage Bio Therapeutic Drugs United Kingdom
Lifted Ventures Anya

2025

Seed Stage Healthcare Facilities & Services (NEC) United Kingdom
redalpine, IQ Capital Partners, Seedcamp DaltonTx

2025

Seed Stage Proprietary & Advanced Pharmaceuticals United Kingdom

Arāya Ventures

invested in

Unfabled

in 2025

in a Seed Stage deal

Disclosed details

Transaction Size: $2M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert